A-582941, cholinergic alpha 7 nicotinic receptor agonist, improved cognitive and negative symptoms of the sub-chronic MK-801 model of schizophrenia in rats
OBJECTIVES Nicotinic receptor systems are involved in a wide variety of behavioural functions, including cognitive function, and nicotinic medications, may provide beneficial treatment for cognitive dysfunctions such as schizophrenia. According to the results of postmortem studies of schizophrenic p...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AVES
2018-01-01
|
| Series: | Psychiatry and Clinical Psychopharmacology |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/24750573.2017.1379716 |